UBS Group AG - OASMIA PHARMACEUTICAL AB ownership

OASMIA PHARMACEUTICAL AB's ticker is OASMY and the CUSIP is 67421W109. A total of 1 filers reported holding OASMIA PHARMACEUTICAL AB in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of OASMIA PHARMACEUTICAL AB
ValueSharesWeighting
Q2 2019$3,000
-62.5%
2,723
-24.9%
0.00%
Q1 2019$8,000
-33.3%
3,624
-10.3%
0.00%
Q4 2018$12,0000.0%4,041
+46.7%
0.00%
Q3 2018$12,000
+1100.0%
2,755
+224.1%
0.00%
Q2 2018$1,000
-66.7%
850
-67.0%
0.00%
Q1 2018$3,000
+50.0%
2,573
+26.2%
0.00%
Q4 2017$2,000
-50.0%
2,039
-44.0%
0.00%
Q3 2017$4,000
-50.0%
3,641
-50.3%
0.00%
Q2 2017$8,0007,327
+6560.9%
0.00%
Q1 2017$0
-100.0%
110
-94.2%
0.00%
Q4 2015$7,0001,9000.00%
Other shareholders
OASMIA PHARMACEUTICAL AB shareholders Q3 2019
NameSharesValueWeighting ↓
Sio Capital Management, LLC 122,100$365,0000.25%
Tower Research Capital LLC (TRC) 800$2,0000.00%
View complete list of OASMIA PHARMACEUTICAL AB shareholders